| This article has been cited by |
| 1 | Effects of Hypolipidemic Drugs on Psoriasis | |
| Mateusz Matwiejuk,Hanna Mysliwiec,Olivia Jakubowicz-Zalewska,Adrian Chabowski,Iwona Flisiak |
| Metabolites.2023;13(4)493 |
| [DOI] |
|
| 2 | The Role of Transcription Factor PPAR-? in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells | |
| Vladimir V. Sobolev,Ekaterina Tchepourina,Irina M. Korsunskaya,Natalia A. Geppe,Svetlana N. Chebysheva,Anna G. Soboleva,Alexandre Mezentsev |
| International Journal of Molecular Sciences.2022;23(17)9708 |
| [DOI] |
|
| 3 | Long noncoding RNA (taurine upregulated gene 1) and micro RNA-377: emerging players in the development of metabolic syndrome among psoriasis patients | |
| Maha Alhelf,Laila Rashed,R. W. Doss,Sahar M. Mohamed,Naglaa Adly) Abd Elazeem |
| Beni-Suef University Journal of Basic and Applied Sciences.2023;12(1)9708 |
| [DOI] |
|
| 4 | Peroxisome proliferator-activator receptor ? and psoriasis, molecular and cellular biochemistry | |
| Xiran Lin,Xianmin Meng,Zhiqi Song,Jingrong Lin |
| Molecular and Cellular Biochemistry.2022;477(7)1905 |
| [DOI] |
|
| 5 | Treatment Modalities of Psoriasis: A Focus on Requisite for Topical Nanocarrier | |
| Arya K. Ramanunny,Sheetu Wadhwa,Divya Thakur,Sachin K. Singh,Rajesh Kumar |
| Endocrine, Metabolic & Immune Disorders - Drug Targets.2021;21(3)418 |
| [DOI] |
|
| 6 | Methotrexate dosing regimen for plaque-type psoriasis: an update of a systematic review | |
| Astrid M. van Huizen,Rosie Sikkel,Anouk G.M. Caron,Stef P. Menting,Phyllis I. Spuls |
| Journal of Dermatological Treatment.2022;33(8)3104 |
| [DOI] |
|
